ZVRA
Zevra Therapeutics Inc.
Company Overview
| Mkt Cap | $430.56M | Price | $10.18 |
| Volume | 927.73K | Change | +0.39% |
| P/E Ratio | -4.1 | Open | $10.19 |
| Revenue | $23.6M | Prev Close | $10.14 |
| Net Income | $-105.5M | 52W Range | $6.19 - $13.16 |
| Div Yield | N/A | Target | $23.71 |
| Overall | 54 | Value | 60 |
| Quality | 52 | Technical | 50 |
No chart data available
Stock Overview
Updated DailyZevra Therapeutics Inc. (ZVRA) is a leading diversified company in the business industry, currently trading at $10.18 with a market capitalization of $430.56 million. The stock is trading in the middle of its 52-week range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows ZVRA with a volume of 928K shares. The stock opened up 0.49% from yesterday's close of $10.14. Current analyst estimates project earnings of $-0.08 per share for this year, with next year targeting $0.62.
ZVRA demonstrates neutral technical outlook based on technical analysis. The company trades on the NGS exchange.
Key investment considerations for ZVRA include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 132.9%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 03:53 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ZVRA | $10.18 | +0.4% | 927.73K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |